CA
VMD icon

Clearstead Advisors’s Viemed Healthcare VMD Stock Holding History

Clearstead Advisors’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69 Buy
+6
New +$59 ﹤0.01% 3426
2025
Q4 		– Sell
-1
Closed -$7 – 3272
2025
Q3 		$7 Buy
+1
New +$7 ﹤0.01% 3060

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Clearstead Advisors's VMD Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Viemed Healthcare (VMD) in Q2 2026: 6 shares worth $69. The stake represents ﹤0.01% of the portfolio and ranks #3426 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in VMD as recently as Q3 2025.

Clearstead Advisors first reported a position in VMD in Q3 2025 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Clearstead Advisors held 6 shares of Viemed Healthcare worth $69 as of Q2 2026.
  • Viemed Healthcare was a new Clearstead Advisors position in Q2 2026.
  • Viemed Healthcare made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3426 holding.
  • Clearstead Advisors first reported a position in Viemed Healthcare in Q3 2025 and has held it in 2 quarters since.
  • 61 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.